These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3830430)

  • 21. Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase.
    Sheng L; Qian Z; Zheng S; Xi L
    Eur J Pharmacol; 2006 Aug; 543(1-3):116-22. PubMed ID: 16828739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypolipidemic effect of the polysaccharides from Porphyra yezoensis.
    Qian L; Zhou Y; Ma JX
    Int J Biol Macromol; 2014 Jul; 68():48-9. PubMed ID: 24736124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
    Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
    Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypolipidemic Effect of a Blue-Green Alga (Nostoc commune) Is Attributed to Its Nonlipid Fraction by Decreasing Intestinal Cholesterol Absorption in C57BL/6J Mice.
    Ku CS; Kim B; Pham TX; Yang Y; Weller CL; Carr TP; Park YK; Lee JY
    J Med Food; 2015 Nov; 18(11):1214-22. PubMed ID: 26161942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partially Purified Aqueous Fraction of Desmodium gyrans DC Improves Reverse Cholesterol Transport and Lipoprotein Metabolism in Wistar Rats Fed with High Fat Diet.
    Indu MS; Padikkala J; Raghavamenon AC
    J Environ Pathol Toxicol Oncol; 2018; 37(1):27-41. PubMed ID: 29772998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hypolipidemic drugs on hepatic CoA.
    Halvorsen O
    Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of SF-482 on bile, gallstones formation and experimental hyperlipemias.
    Coppi G; Gatti MT; Mosconi P; Berti MA
    Arch Int Pharmacodyn Ther; 1988; 294():283-94. PubMed ID: 3233053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hepatic gluconeogenesis and lipogenesis by benzoic acid, p-tert.-butylbenzoic acid, and a structurally related hypolipidemic agent SC-33459.
    McCune SA; Durant PJ; Flanders LE; Harris RA
    Arch Biochem Biophys; 1982 Mar; 214(1):124-33. PubMed ID: 7081992
    [No Abstract]   [Full Text] [Related]  

  • 31. GUGULIPID: a natural cholesterol-lowering agent.
    Urizar NL; Moore DD
    Annu Rev Nutr; 2003; 23():303-13. PubMed ID: 12626688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of eritadenine on cholesterol metabolism in the rat.
    Takashima K; Sato C; Sasaki Y; Morita T; Takeyama S
    Biochem Pharmacol; 1974 Jan; 23(2):433-8. PubMed ID: 4813355
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of 3-hydroxy-3-methylglutaric acid on blood lipids in normal and cholesterol-fed rats.
    Beg ZH; Siddiqi M
    Experientia; 1968 Aug; 24(8):791-2. PubMed ID: 5683167
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypolipidemic activity of Tamarix articulata Vahl. in diabetic rats.
    Hebi M; Eddouks M
    J Integr Med; 2017 Nov; 15(6):476-482. PubMed ID: 29103418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental investigation of hypolipidemic and anti-atherosclerotic drugs with different mechanism of action.
    Klimov AN; Ryzhenkov VE; Petrova LA; Polyakova ED
    Adv Exp Med Biol; 1977; 82():477-82. PubMed ID: 920403
    [No Abstract]   [Full Text] [Related]  

  • 36. Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidemic drugs.
    Ciriolo MR; Mavelli I; Rotilio G; Borzatta V; Cristofari M; Stanzani L
    FEBS Lett; 1982 Aug; 144(2):264-8. PubMed ID: 7117540
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on hypolipidemic agents. III. Synthesis and esterase-inhibitory activity of omega-cycloalkyl-2-oxoalkyl arenesulfonates.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Fujii S
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2426-36. PubMed ID: 3664839
    [No Abstract]   [Full Text] [Related]  

  • 38. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.
    Haughom B; Spydevold O
    Biochim Biophys Acta; 1992 Sep; 1128(1):65-72. PubMed ID: 1327145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats.
    Ji W; Gong BQ
    J Ethnopharmacol; 2008 Sep; 119(2):291-8. PubMed ID: 18691646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of beclobrate on lipid/lipoprotein distribution in normal and hypercholesterolemic rats.
    Manzoni C; Lovati MR; Bonelli A; Galli G; Sirtori CR
    Eur J Pharmacol; 1990 Nov; 190(1-2):39-49. PubMed ID: 2076759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.